Regeneron

brand-profile-thumb

Company Headquarters

777 Old Saw Mill River Road Tarrytown, New York 10591 US

Driving Directions

Brand Description

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we

Key Personnel

NAME
JOB TITLE
  • Leonard S. Schleifer, MD, PhD
    Board co-Chair, President and Chief Executive Officer
  • George D. Yancopoulos, MD, PhD
    Board co-Chair, President and Chief Scientific Officer
  • Zoran Berkovic
    Senior Vice President, Financial Planning and Analysis
  • Maya Bermingham
    Senior Vice President, Public Policy and Government Affairs
  • Leonard Brooks
    Senior Vice President, Treasurer
  • John Calabro
    Senior Vice President, Internal Audit
  • Christina Chan
    Senior Vice President, Corporate Affairs
  • Larry Coury, PhD
    Senior Vice President, Associate General Counsel
  • Ryan Crowe
    Senior Vice President, Investor Relations & Strategic Analysis
  • Matthew Everett
    Senior Vice President, Global Procurement
  • Chris Fenimore
    Senior Vice President, Finance and Chief Financial Officer
  • Rick Hall
    Senior Vice President, Human Resources
  • Justin Holko
    Senior Vice President, Global Oncology/Hematology Commercial Business Unit
  • Nouhad Husseini
    Senior Vice President, Business Development
  • Joseph J. LaRosa
    Executive Vice President, General Counsel and Secretary
  • Melissa Lozner
    Senior Vice President, Chief Compliance Officer
  • Marion McCourt
    Executive Vice President, Commercial
  • Bob McCowan
    Senior Vice President, IT and Chief Information Officer
  • Gonzalo Merino, PhD
    Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel
  • Richard O
    Senior Vice President, Market Access
  • Sally A. Paull
    Executive Vice President, Human Resources
  • Smita Pillai
    Senior Vice President, Culture and DEI and Chief DEI Officer
  • George Poth
    Senior Vice President, Real Estate & Facilities Management
  • Alessandra Ravetti
    Senior Vice President, Associate General Counsel
  • Kerry Reinertsen, PhD
    Senior Vice President, Strategic Alliances
  • David Snow
    Senior Vice President, Global Head, Dupixent Franchise
  • Mark Volpe
    Senior Vice President, Tax
  • Bola Akinlade, MD, FACP
    Senior Vice President, Clinical Development, Immunology and Inflammation
  • Hanne Bak, PhD
    Senior Vice President, Preclinical Manufacturing and Process Development
  • Aris Baras, MD
    Senior Vice President, Regeneron Genetics Center
  • Ned Braunstein, MD
    Executive Vice President, Regulatory Affairs and Global Patient Safety
  • Gang Chen, PhD
    Senior Vice President, Protein Expression Sciences
  • Thomas DiCioccio, PhD
    Senior Vice President, Pharmacometrics
  • Benjamin Drosman
    Senior Vice President, Global Development Quality & Regulatory Compliance
  • Gregory Geba, MD, PhD
    Senior Vice President, Global Development Scientific Council
  • Philip Gregory, DPhil
    Senior Vice President, Regeneron Cell Medicines
  • Gary Herman, MD
    Senior Vice President, Early Clinical Development and Experimental Sciences
  • Boaz Hirshberg, MD
    Senior Vice President, Clinical Sciences General Medicine
  • Diana Hughes, MBBS
    Senior Vice President, Global Patient Safety
  • Bari Kowal
    Senior Vice President, Development Operations and Portfolio Management
  • Christos Kyratsous, PhD
    Senior Vice President, Research
  • Johnathan Lancaster, MD, PhD
    Senior Vice President, Global Medical Affairs
  • John Lin, MD, PhD
    Senior Vice President, Immuno-Oncology and Head of Bispecifics
  • Israel Lowy, MD, PhD
    Senior Vice President, Translational and Clinical Sciences, Oncology
  • Lynn Macdonald, PhD
    Senior Vice President, Research
  • Lori Morton, PhD
    Senior Vice President, Research
  • Andrew Murphy, PhD
    Executive Vice President, Research
  • Muriel O'Byrne, PhD
    Senior Vice President, International Regulatory Affairs & Head, European Business Office
  • William Olson, PhD
    Senior Vice President, Therapeutic Proteins
  • Mohammed Shameem, PhD
    Senior Vice President, Formulations Development
  • L. Andres Sirulnik, MD, PhD
    Senior Vice President, Translational and Clinical Sciences, Hematology
  • Randy Soltys, PhD
    Senior Vice President, Drug Safety and Pharmacometrics
  • Neil Stahl, PhD
    Executive Vice President, Research and Development
  • Robert Vitti, MD
    Senior Vice President, Clinical Trial Excellence Strategy
  • Brian Zambrowicz, PhD
    Executive Vice President, Functional Genomics and Chief
  • Rajesh Ahuja
    Senior Vice President, Fill/Finish and External Manufacturing
  • Frederick Austin
    Senior Vice President, Quality Control, Raheen
  • Christine Childrose
    Senior Vice President, Human Resources and HR Operations
  • David Crenshaw
    Senior Vice President, Associate General Counsel
  • Tikiri Dissanayake
    Senior Vice President, IOPS Technical Operations
  • Patrice Gilooly
    Senior Vice President, Quality Assurance and Operations
  • Jenny McNay, PhD
    Senior Vice President, CMC Regulatory Sciences and Industrial Affairs
  • Niall O
    Senior Vice President and Site Head, IOPS Raheen
  • Scott Oberman
    Senior Vice President, Supply Chain Operations
  • David Simon
    Senior Vice President, IOPS Finance and Business Operations
  • Daniel Van Plew
    Executive Vice President and General Manager, Industrial Operations and Product Supply
  • Benjamin Yocum
    Senior Vice President, Manufacturing Operations
  • James Wolfe
    Senior Vice President, Process Sciences and Drug Product Engineering

Yearly results

Sales: 858 Million

Headcount: 1,950
Bio/Pharma Revenues: $858 (1807%)
Total Revenues: $1,378 (209%)
Net Income: $750 (n/a)
R&D Budget: $626 (18%)

Top Selling Drugs

Drug Indication $ (+/- %)
Eylea wet AMD $838 4090%

Account for 98% of total biopharma sales, up from 44% in 2011

Related Content